Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123110803 | 12311080 | 3 | F | 201503 | 20160714 | 20160427 | 20160722 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-032243 | BRISTOL MYERS SQUIBB | 68.73 | YR | F | Y | 42.18000 | KG | 20160722 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123110803 | 12311080 | 1 | PS | ELIQUIS | APIXABAN | 1 | Unknown | 2.5 MG, BID | Y | 202155 | 2.5 | MG | BID | ||||||
| 123110803 | 12311080 | 2 | SS | REVATIO | SILDENAFIL CITRATE | 1 | Oral | 20 MG, TID | U | A527301/A410702 | 0 | 20 | MG | TID | |||||
| 123110803 | 12311080 | 3 | SS | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Unknown | UNK UNK, QD | U | 0 | QD | ||||||||
| 123110803 | 12311080 | 4 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Unknown | 100 ?G, QD | U | 0 | 100 | UG | QD | ||||||
| 123110803 | 12311080 | 5 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Unknown | 1 ?G, QD | U | 0 | 1 | UG | QD | ||||||
| 123110803 | 12311080 | 6 | C | ALBUTEROL /00139501/ | ALBUTEROL | 1 | Oral | 1 TAB, QID | U | 0 | 1 | DF | QID | ||||||
| 123110803 | 12311080 | 7 | C | ALBUTEROL /00139501/ | ALBUTEROL | 1 | U | 0 | |||||||||||
| 123110803 | 12311080 | 8 | C | TORSEMIDE. | TORSEMIDE | 1 | Unknown | 1 TAB, QD | U | 0 | 1 | DF | QD | ||||||
| 123110803 | 12311080 | 9 | C | TORSEMIDE. | TORSEMIDE | 1 | Unknown | 20 MG, UNK | U | 0 | 20 | MG | |||||||
| 123110803 | 12311080 | 10 | C | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | Oral | 40 MG, QD | U | 0 | 40 | MG | QD | ||||||
| 123110803 | 12311080 | 11 | C | HYDROCODONE | HYDROCODONE | 1 | Unknown | 1 TAB, Q8H | U | 0 | 1 | DF | TID | ||||||
| 123110803 | 12311080 | 12 | C | TRAMADOL. | TRAMADOL | 1 | Oral | 1 TAB, TID | U | 0 | 1 | DF | TID | ||||||
| 123110803 | 12311080 | 13 | C | FLONASE /00908302/ | MOMETASONE FUROATE | 1 | Unknown | 50 ?G, QD | U | 0 | 50 | UG | QD | ||||||
| 123110803 | 12311080 | 14 | C | FLONASE /00908302/ | MOMETASONE FUROATE | 1 | Nasal | UNK | U | 0 | QD | ||||||||
| 123110803 | 12311080 | 15 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | 1 DF, BID | U | 0 | 1 | DF | BID | ||||||
| 123110803 | 12311080 | 16 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | UNK, QD | U | 0 | QD | ||||||||
| 123110803 | 12311080 | 17 | C | ALBUTEROL HFA | ALBUTEROL SULFATE | 1 | Unknown | UNK, PRN | U | 0 | |||||||||
| 123110803 | 12311080 | 18 | C | ALBUTEROL HFA | ALBUTEROL SULFATE | 1 | U | 0 | |||||||||||
| 123110803 | 12311080 | 19 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Unknown | 40 MG, QD | U | 0 | 40 | MG | QD | ||||||
| 123110803 | 12311080 | 20 | C | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | Unknown | 40 MG, QD | U | 0 | 40 | MG | QD | ||||||
| 123110803 | 12311080 | 21 | C | CALTRATE /00944201/ | 2 | Unknown | 1 DF, QD | U | 0 | 1 | DF | QD | |||||||
| 123110803 | 12311080 | 22 | C | ALBUMIN | ALBUMIN HUMAN | 1 | Ophthalmic | 5 %, TID | U | 0 | 5 | PCT | TID | ||||||
| 123110803 | 12311080 | 23 | C | POTASSIUM | POTASSIUM | 1 | Unknown | UNK, QD | U | 0 | QD | ||||||||
| 123110803 | 12311080 | 24 | C | VITIRON /02135501/ | 2 | Unknown | UNK, QD | U | 0 | QD | |||||||||
| 123110803 | 12311080 | 25 | C | OMEGA 3 /01333901/ | FISH OILTOCOPHEROL | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123110803 | 12311080 | 1 | Product used for unknown indication |
| 123110803 | 12311080 | 2 | Pulmonary hypertension |
| 123110803 | 12311080 | 3 | Product used for unknown indication |
| 123110803 | 12311080 | 4 | Thyroid disorder |
| 123110803 | 12311080 | 6 | Asthma |
| 123110803 | 12311080 | 7 | Pulmonary hypertension |
| 123110803 | 12311080 | 8 | Cardiac disorder |
| 123110803 | 12311080 | 10 | Anxiety |
| 123110803 | 12311080 | 11 | Nervous system disorder |
| 123110803 | 12311080 | 12 | Nervous system disorder |
| 123110803 | 12311080 | 13 | Hypersensitivity |
| 123110803 | 12311080 | 15 | Pulmonary hypertension |
| 123110803 | 12311080 | 17 | Dyspnoea |
| 123110803 | 12311080 | 18 | Asthma |
| 123110803 | 12311080 | 19 | Product used for unknown indication |
| 123110803 | 12311080 | 20 | Product used for unknown indication |
| 123110803 | 12311080 | 21 | Product used for unknown indication |
| 123110803 | 12311080 | 22 | Dry eye |
| 123110803 | 12311080 | 23 | Product used for unknown indication |
| 123110803 | 12311080 | 24 | Iron deficiency |
| 123110803 | 12311080 | 25 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123110803 | 12311080 | OT |
| 123110803 | 12311080 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123110803 | 12311080 | Cardiac pacemaker insertion | |
| 123110803 | 12311080 | Heart rate increased | |
| 123110803 | 12311080 | Hypotension | |
| 123110803 | 12311080 | Nerve compression |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123110803 | 12311080 | 1 | 201503 | 20160117 | 0 | |
| 123110803 | 12311080 | 3 | 20130625 | 0 | ||
| 123110803 | 12311080 | 11 | 201503 | 0 | ||
| 123110803 | 12311080 | 12 | 201503 | 0 |